Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 28, 2017	Jan. 30, 2016	Jan. 31, 2015
Cash flows from operating activities:
Net loss	$ (2,256)	$ (8,408)	$ (12,295)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization of deferred gain on sale-leaseback	(1,466)	(1,465)	(1,466)
Amortization of deferred debt issuance costs	276	279	192
Depreciation and amortization	30,621	28,359	24,002
Deferred taxes, net of valuation allowance	26	105	91
Stock compensation expense	1,256	2,195	2,996
Issuance of common stock to Board of Directors	482	540	273
Changes in operating assets and liabilities:
Accounts receivable	(2,393)	(1,102)	4,728
Inventories	7,568	(9,794)	(9,664)
Prepaid expenses and other current assets	(563)	659	(1,196)
Other assets	(247)	350	(667)
Accounts payable	574	705	(2,966)
Deferred rent and lease incentives	4,487	2,084	6,015
Accrued expenses and other liabilities	(3,405)	3,883	3,762
Net cash provided by operating activities	34,960	18,390	13,805
Cash flows from investing activities:
Additions to property and equipment, net	(29,239)	(33,447)	(40,927)
Net cash used for investing activities	(29,239)	(33,447)	(40,927)
Cash flows from financing activities:
Net borrowings under credit facility	1,993	23,044	10,373
Proceeds from the issuance of long-term debt			23,912
Principal payments on long-term debt	(7,312)	(7,489)	(6,478)
Costs associated with debt issuances		(15)	(766)
Proceeds from the exercise of stock options		101	123
Net cash provided by (used for) financing activities	(5,319)	15,641	27,164
Net increase in cash and cash equivalents	402	584	42
Cash and cash equivalents:
Beginning of period	5,170	4,586	4,544
End of period	$ 5,572	$ 5,170	$ 4,586